Metagenomi Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold MGX, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
6
Funds holding
$613449
Total value held
Buying
2 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $308379 | 230134 | +5993 | +2.67% |
| 2 | State Street Corp | $161372 | 120427 | — | Held |
| 3 | Northern Trust Corp | $100730 | 75172 | — | Held |
| 4 | Morgan Stanley | $36938 | 27566 | -32116 | -53.81% |
| 5 | Us Bancorp \De\ | $6030 | 4500 | — | Held |
| 6 | Royal Bank Of Canada | $0 | 314 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.